GERN logo

GERN
Geron Corp.

21,335
Mkt Cap
$898.13M
Volume
2.48M
52W High
$2.01
52W Low
$1.04
PE Ratio
-13.42
GERN Fundamentals
Price
$1.32
Prev Close
$1.40
Open
$1.38
50D MA
$1.57
Beta
1.23
Avg. Volume
18.37M
EPS (Annual)
-$0.1252
P/B
3.92
Rev/Employee
$712,717.05
$771.77
Loading...
Loading...
News
all
press releases
Geron Q1 Earnings Call Highlights
Geron (NASDAQ:GERN) reported first-quarter 2026 net revenue of $61.8 million, up 31% year-over-year and 8% quarter-over-quarter, as the company continued to scale commercialization of Rytelo in the...
MarketBeat·9d ago
News Placeholder
More News
News Placeholder
Geron (GERN) Reports Q1 Loss, Beats Revenue Estimates
Geron (GERN) delivered earnings and revenue surprises of +60.00% and +2.94%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·9d ago
News Placeholder
Geron (NASDAQ:GERN) Stock Price Passes Above 200-Day Moving Average - What's Next?
Geron (NASDAQ:GERN) Shares Pass Above 200 Day Moving Average - Here's What Happened...
MarketBeat·17d ago
News Placeholder
Sweden Will Consider Ways To Limit Energy Use If Iran War Continues, Government Says
Sweden Will Consider Ways To Limit Energy Use If Iran War Continues, Government Says Authored by Victoria Friedman via The Epoch Times (emphasis ours), Sweden may need to consider options to reduce energy consumption, including rationing, if the disruption to the flow of fuel supplies...
Zero Hedge·21d ago
News Placeholder
Geron (NASDAQ:GERN) Stock Price Down 5.1% - Here's What Happened
Geron (NASDAQ:GERN) Shares Down 5.1% - Here's What Happened...
MarketBeat·25d ago
News Placeholder
Geron Corporation (NASDAQ:GERN) Receives Average Rating of "Hold" from Brokerages
Geron Corporation (NASDAQ:GERN - Get Free Report) has been assigned an average rating of "Hold" from the seven ratings firms that are currently covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and two have assign...
MarketBeat·29d ago
News Placeholder
Geron Highlights RYTELO Launch, 2026 Revenue Outlook and Phase 3 Myelofibrosis Plans at Needham Conf
Geron (NASDAQ:GERN) executives used a presentation at the Needham Healthcare Conference to outline the company's early commercial trajectory for its telomerase inhibitor imetelstat (marketed as...
MarketBeat·1mo ago
News Placeholder
Aberdeen Group plc Boosts Stock Holdings in Geron Corporation $GERN
Aberdeen Group plc grew its stake in shares of Geron Corporation (NASDAQ:GERN - Free Report) by 59.6% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional...
MarketBeat·1mo ago
News Placeholder
Geron (NASDAQ:GERN) Trading Up 9.7% - What's Next?
Geron (NASDAQ:GERN) Stock Price Up 9.7% - Here's Why...
MarketBeat·1mo ago
News Placeholder
Geron (NASDAQ:GERN) Share Price Passes Above 200 Day Moving Average - What's Next?
Geron (NASDAQ:GERN) Shares Pass Above 200-Day Moving Average - Should You Sell...
MarketBeat·2mo ago
<
1
2
...
>

Latest GERN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.